Chimeric Therapeutics Limited (CHMMF)

Chimeric Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	5.76	3.05	2.36	18.38	22.41
Cash & Short-Term Investments	5.76	3.05	2.36	18.38	22.41
Cash Growth	88.58%	29.22%	-87.15%	-17.98%	22410099.00%
Accounts Receivable	4.55	0.09	6.66	0.04	-
Other Receivables	-	-	-	2.62	0.02
Receivables	4.55	0.09	6.66	2.66	0.02
Other Current Assets	0.22	0.08	0.33	0.13	0.23
Total Current Assets	10.53	3.22	9.35	21.17	22.67
Property, Plant & Equipment	-	0	0.01	0.02	0.01
Long-Term Investments	-	0.04	0.04	0.04	-
Other Intangible Assets	11.04	12.01	12.98	13.65	13.83
Total Assets	21.57	15.27	22.38	34.88	36.5
Accounts Payable	6.57	3.2	7.41	4.7	2.04
Accrued Expenses	1.75	3.24	3.77	1.83	1.06
Other Current Liabilities	6.3	3.66	3.52	2.49	4.26
Total Current Liabilities	14.61	10.1	14.69	9.02	7.35
Other Long-Term Liabilities	4.98	2.71	2.02	0.15	4.02
Total Liabilities	19.6	12.8	16.71	9.17	11.37
Common Stock	70.16	63.51	53.93	51.81	37.37
Retained Earnings	-76.33	-66.56	-56.78	-30.86	-15.18
Comprehensive Income & Other	8.15	5.52	8.51	4.76	2.94
Shareholders' Equity	1.97	2.47	5.66	25.71	25.13
Total Liabilities & Equity	21.57	15.27	22.38	34.88	36.5
Net Cash (Debt)	5.76	3.05	2.36	18.38	22.41
Net Cash Growth	88.58%	29.22%	-87.15%	-17.98%	-
Net Cash Per Share	0.00	0.00	0.01	0.05	0.12
Filing Date Shares Outstanding	3,255	905.15	529.4	425.28	330.86
Total Common Shares Outstanding	2,015	876.06	506.69	425.28	330.86
Working Capital	-4.09	-6.87	-5.34	12.15	15.31
Book Value Per Share	0.00	0.00	0.01	0.06	0.08
Tangible Book Value	-9.07	-9.54	-7.32	12.05	11.3
Tangible Book Value Per Share	-0.00	-0.01	-0.01	0.03	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.